1. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus;Vallon;Annu Rev Med,2015
2. Janssen Pharmaceuticals, Inc Prescribing information (05/2016): INVOKANA (canagliflozin) tablets, for oral use http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/204042s015s019lbl.pdf
3. AstraZeneca Pharmaceuticals LP Prescribing information (06/2016): FARXIGA (dapagliflozin) tablets, for oral use http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/202293s009lbl.pdf
4. Boehringer Ingelheim Pharmaceuticals Inc Prescribing information (07/2016): JARDIANCE (empagliflozin) tablets, for oral use http://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Jardiance/jardiance.pdf
5. 7. Approaches to Glycemic treatment;American Diabetes Association;Diabetes Care,2016